Wahid Doss

2.6k total citations
72 papers, 1.3k citations indexed

About

Wahid Doss is a scholar working on Hepatology, Epidemiology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Wahid Doss has authored 72 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Hepatology, 63 papers in Epidemiology and 5 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Wahid Doss's work include Hepatitis C virus research (60 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (37 papers). Wahid Doss is often cited by papers focused on Hepatitis C virus research (60 papers), Liver Disease Diagnosis and Treatment (59 papers) and Hepatitis B Virus Studies (37 papers). Wahid Doss collaborates with scholars based in Egypt, France and United States. Wahid Doss's co-authors include Gamal Esmat, Mohamed Hassany, Wafaa Elakel, Imam Waked, Manal H. El‐Sayed, Mohamed El‐Kassas, Magdy El‐Serafy, Kadry Elsaeed, Marwa Khairy and Gamal Shiha and has published in prestigious journals such as SHILAP Revista de lepidopterología, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

Wahid Doss

69 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wahid Doss Egypt 20 1.1k 1.0k 105 74 56 72 1.3k
Mohamed Hassany Egypt 16 775 0.7× 778 0.8× 134 1.3× 54 0.7× 36 0.6× 95 1.0k
G Teuber Germany 25 1.5k 1.4× 1.3k 1.3× 204 1.9× 171 2.3× 103 1.8× 108 1.7k
Alnoor Ramji Canada 21 1.2k 1.1× 1.2k 1.1× 168 1.6× 56 0.8× 192 3.4× 82 1.4k
Montserrat Garcı́a-Retortillo Spain 17 1.6k 1.4× 1.4k 1.4× 73 0.7× 34 0.5× 204 3.6× 52 1.7k
Mark Sonderup South Africa 18 671 0.6× 715 0.7× 272 2.6× 35 0.5× 44 0.8× 64 1.1k
J. Medraño Spain 20 690 0.6× 705 0.7× 448 4.3× 86 1.2× 50 0.9× 43 1.2k
Janaína Luz Narciso-Schiavon Brazil 18 678 0.6× 680 0.7× 56 0.5× 68 0.9× 134 2.4× 83 966
Dolores Merino Spain 19 955 0.9× 916 0.9× 348 3.3× 36 0.5× 47 0.8× 68 1.2k
L Viladomiu Spain 14 1.6k 1.4× 1.5k 1.5× 179 1.7× 73 1.0× 163 2.9× 25 1.8k
David Iser Australia 20 1.1k 1.0× 1.2k 1.1× 183 1.7× 16 0.2× 74 1.3× 55 1.4k

Countries citing papers authored by Wahid Doss

Since Specialization
Citations

This map shows the geographic impact of Wahid Doss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wahid Doss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wahid Doss more than expected).

Fields of papers citing papers by Wahid Doss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wahid Doss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wahid Doss. The network helps show where Wahid Doss may publish in the future.

Co-authorship network of co-authors of Wahid Doss

This figure shows the co-authorship network connecting the top 25 collaborators of Wahid Doss. A scholar is included among the top collaborators of Wahid Doss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wahid Doss. Wahid Doss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
El‐Kassas, Mohamed, Wafaa Elakel, Aisha Elsharkawy, et al.. (2024). Comparison of different noninvasive scores for assessing hepatic fibrosis in a cohort of chronic hepatitis C patients. Scientific Reports. 14(1). 29544–29544. 1 indexed citations
2.
Hassany, Mohamed, Wafaa Elakel, Mohamed AbdAllah, et al.. (2022). Seroprevalence of HBV/HCV coinfection among patients with HCV screened during the national campaign for HCV eradication in Egypt. Arab Journal of Gastroenterology. 23(4). 259–262. 3 indexed citations
3.
El‐Kassas, Mohamed, Wafaa Elakel, Mohamed Alboraie, et al.. (2022). Egyptian revalidation of non-invasive parameters for predicting esophageal varices in cirrhotic patients: A retrospective study. Arab Journal of Gastroenterology. 23(2). 120–124.
4.
Mostafa, Aya, Ossama Ashraf Ahmed, Hany Dabbous, et al.. (2021). The outcome of re-treatment of relapsed hepatitis C virus infection in a resource-limited setting. VirusDisease. 32(3). 582–588. 1 indexed citations
5.
El‐Kassas, Mohamed, Mohamed Alboraie, Naglaa Youssef, et al.. (2020). Retreatment of chronic hepatitis C patients who failed previous therapy with directly acting antivirals: A multicenter study. International Journal of Infectious Diseases. 96. 367–370. 5 indexed citations
6.
Abdel‐Razek, Wael, Mohamed Hassany, Manal H. El‐Sayed, et al.. (2019). Hepatitis C Virus in Egypt: Interim Report From the World’s Largest National Program. Clinical Liver Disease. 14(6). 203–206. 18 indexed citations
7.
Yosry, Ayman, Eman Medhat, Naglaa Zayed, et al.. (2018). Efficacy and safety of sofosbuvir‐based therapy in hepatitis C virus recurrence post living donor liver transplant: A real life egyptian experience. Journal of Medical Virology. 91(4). 668–676. 2 indexed citations
8.
El‐Kassas, Mohamed, Dalia Omran, Kadry Elsaeed, et al.. (2018). Spur-of-the-Moment Modification in National Treatment Policies Leads to a Surprising HCV Viral Suppression in All Treated Patients: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 38(2). 81–85. 5 indexed citations
9.
Said, Mohamed, et al.. (2018). High prevalence of HCV (GT4)-related TSH abnormality among 13402 Egyptian patients treated with direct acting antiviral therapy. Hepatology International. 12(2). 143–148. 3 indexed citations
10.
Elbaz, Tamer, Magdy El‐Serafy, Wafaa Elakel, et al.. (2017). Serious Adverse Events with Sofosbuvir Combined with Interferon and Ribavirin: Real-Life Egyptian Experience. Journal of Interferon & Cytokine Research. 37(8). 348–353. 4 indexed citations
11.
Esmat, Gamal, Maissa El Raziky, Aisha Elsharkawy, et al.. (2014). Impact of Vitamin D Supplementation on Sustained Virological Response in Chronic Hepatitis C Genotype 4 Patients Treated by Pegylated Interferon/Ribavirin. Journal of Interferon & Cytokine Research. 35(1). 49–54. 37 indexed citations
12.
Obach, Dorothée, Sylvie Deuffic‐Burban, Gamal Esmat, et al.. (2014). Effectiveness and Cost-effectiveness of Immediate Versus Delayed Treatment of Hepatitis C Virus–Infected Patients in a Country With Limited Resources: The Case of Egypt. Clinical Infectious Diseases. 58(8). 1064–1071. 32 indexed citations
13.
Breban, Romulus, Naglaa Arafa, Sandrine Leroy, et al.. (2014). Effect of preventive and curative interventions on hepatitis C virus transmission in Egypt (ANRS 1211): a modelling study. The Lancet Global Health. 2(9). e541–e549. 32 indexed citations
14.
Obach, Dorothée, Sylvie Deuffic‐Burban, Gamal Esmat, et al.. (2013). 885 IMMEDIATE vs. DELAYED TREATMENT IN GENOTYPE 4-HCV INFECTED PATIENTS IN A LIMITED RESOURCES COUNTRY: A COST-EFFECTIVENESS ANALYSIS IN EGYPT (ANRS 12215). Journal of Hepatology. 58. S364–S364. 2 indexed citations
15.
Mabrouk, Mahasen, Wahid Doss, Naglaa Zayed, Shimaa Afify, & Gamal Esmat. (2013). Impact of Serum Alpha-fetoprotein Levels on the Response to Antiviral Therapy in Egyptian Patients with Chronic Hepatitis C. Journal of Gastroenterology and Hepatology Research. 2(5). 597–601. 3 indexed citations
16.
Saad, Yasmin, et al.. (2013). Adipokines and insulin resistance, predictors of response to therapy in Egyptian patients with chronic hepatitis C virus genotype 4. European Journal of Gastroenterology & Hepatology. 25(8). 920–925. 16 indexed citations
17.
Esmat, Gamal, Aisha Elsharkawy, Wafaa Elakel, et al.. (2013). Fibroscan of chronic HCV patients coinfected with schistosomiasis. Arab Journal of Gastroenterology. 14(3). 109–112. 15 indexed citations
18.
Zayed, Naglaa, Wafaa Elakel, Wahid Doss, et al.. (2012). The assessment of data mining for the prediction of therapeutic outcome in 3719 Egyptian patients with chronic hepatitis C. Clinics and Research in Hepatology and Gastroenterology. 37(3). 254–261. 15 indexed citations
19.
Esmat, Gamal, A. Yosry, Mostafa El-Serafi, et al.. (2005). Donor Outcomes in Right Lobe Adult Living Donor Liver Transplantation: Single-Center Experience in Egypt. Transplantation Proceedings. 37(7). 3147–3150. 14 indexed citations
20.
Hosking, S W, et al.. (1988). Pharmacological constriction of the lower oesophageal sphincter: a simple method of arresting variceal haemorrhage.. Gut. 29(8). 1098–1102. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026